Cargando…
Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine
Cardiovascular disease (CVD) is the leading cause of death worldwide. Management of cardiovascular risk factors, particularly hypertension and dyslipidemia, has been shown to reduce cardiovascular morbidity and mortality. However, current guidelines recommend adjusting the intensity of blood pressur...
Autores principales: | Sofogianni, Areti, Stalikas, Nikolaos, Antza, Christina, Tziomalos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317494/ https://www.ncbi.nlm.nih.gov/pubmed/35887677 http://dx.doi.org/10.3390/jpm12071180 |
Ejemplares similares
-
The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy
por: Kostourou, Danai-Thomais, et al.
Publicado: (2022) -
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
por: Sofogianni, Areti, et al.
Publicado: (2020) -
The Importance of Out-of-Office Blood Pressure Measurement, as Highlighted by the Correlation with Left Ventricular Hypertrophy in an Untreated Hypertensive Population
por: Antza, Christina, et al.
Publicado: (2023) -
Novel Cardiovascular Risk Factors in Patients with Diabetic Kidney Disease
por: Kourtidou, Christodoula, et al.
Publicado: (2021) -
The Depiction of Hypertension in Heart Imaging Examinations: An Up-to-Date Review of the Evidence
por: Vasileiadis, Konstantinos, et al.
Publicado: (2023)